Tumor markers and neutrophil-lymphocyte ratio’s predictive role in endometriosis
Abstract
Full text
2,332 characters
· extracted from
oa-doi-fallback
· 5 sections
· click to expand
Abstract
Material and methods
Results
Conclusion
Keywords
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (10)
- Blood biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Diagnostic value of the neutrophil-to-lymphocyte ratio and the combination of serum CA-125 for stages III and IV endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: epidemiology and aetiological factors via openalex
- New insights into the pathophysiology of endometriosis: from chronic inflammation to danger signal via openalex
- Peripheral biomarkers of endometriosis: a systematic review via openalex
- Update on Biomarkers for the Detection of Endometriosis via openalex
- W2158516834 via openalex
- W2283760758 via openalex
- W4211081176 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00